The Europe Research-grade Proteins Market would witness market growth of 15.0% CAGR during the forecast period (2023-2030).
The market for research-grade proteins is competitive and includes established and smaller biotechnology firms. Some well-known players in this industry include Thermo Fisher Scientific, Sigma-Aldrich (now part of MilliporeSigma), Abcam, Bio-Rad Laboratories, and Novus Biologicals. Many suppliers in this market offer customized solutions, allowing researchers to order proteins tailored to their specific research needs. Additionally, specialized companies may focus on particular classes of proteins or specific research areas. High-quality and highly pure proteins are critical for research accuracy and reproducibility.
These are distributed through various channels, including direct sales, distributors, and online marketplaces. Researchers can order these products directly from suppliers or through laboratory procurement systems. Suppliers in this market must adhere to regulatory standards and guidelines, mainly if they produce proteins for diagnostics or therapeutic applications. Compliance with good manufacturing practices and other relevant regulations is crucial.
Europe boasts a robust life sciences sector, with leading research institutions and universities conducting cutting-edge research in genomics, proteomics, drug discovery, and molecular biology. These research activities fuel the demand for research-grade proteins. Europe has a thriving pharmaceutical industry, with many companies involved in developing innovative drugs and biopharmaceuticals. Europe has seen the emergence of numerous biotech startups and entrepreneurial ventures focused on various aspects of the life sciences. Many of these startups require research-grade proteins for their research and development activities.
The Germany region dominated the Europe Research-grade Proteins Market, by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $163.7 Million by 2030. The UK market is exhibiting a CAGR of 14% during (2023 - 2030). Additionally, The France market would experience a CAGR of 15.8% during (2023 - 2030).
Based on Host Cell, the market is segmented into Mammalian Cells, Bacterial Cells, Yeast & Fungi, Insect Cells, and Others. Based on Product, the market is segmented into Cytokines & Growth Factors, Immune Checkpoint Proteins, Enzymes, Hormones, Antibodies, Virus Antigens, Recombinant Regulatory Proteins, and Others. Based on End-use, the market is segmented into Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Global Research-grade Proteins Market will Hit $2.5 Billion by 2030, at a CAGR of 15.2%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Thermo Fisher Scientific, Inc., Abcam Plc, Miltenyi Biotech B.V. & Co. KG, Genscript Biotech Corporation, Bio-Techne Corporation, Proteintech Group, Inc., AcroBiosystems INC., Sino Biologicals, Inc. and ProSpec-Tany TechnoGene Ltd. and New England Biolabs, Inc.
By Host Cell
By Product
By End-use
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 